Stake logo

ANIX

Anixa Biosciences, Inc.

About ANIX

Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others. Its vaccine programs include the development of a preventative vaccine against triple-negative breast cancer (TNBC), the lethal form of breast cancer, as well other forms of breast cancer, and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell (CAR- T) technology that is focused on treating ovarian cancer, which is developed at its subsidiary, Certainty Therapeutics, Inc., and the development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus.

Buy US stocks in Australia starting with ANIX. Open an account and start investing today!

Market Capitalisation

$141.32M

Price-earnings ratio

-

Dividend yield

0.00%

Volume

0

High today

$4.50

Low today

$4.31

Open price

$0.00

52-week high

$6.25

52-week low

$2.30


ANIX FAQs

One share of Anixa Biosciences, Inc. is valued at $4.34.

The ticker symbol for Anixa Biosciences, Inc. is ANIX.

To buy ANIX stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
  1. Sign up in minutes, all you need is some I.D.
  2. Choose Stake Wall St
  3. Deposit directly into your Stake wallet and you're ready to invest in ANIX

As of 07/02/2023 Anixa Biosciences, Inc. has a market cap of $141M.

The Anixa Biosciences, Inc. 52-week high stock price is $6.25.

The Anixa Biosciences, Inc. 52-week low stock price is $2.30.


Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.